Stock Research for CDXS


Featured Broker: Ally Invest

Get the due diligence for another stock.


CDXS Stock Chart & Research Data

The CDXS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CDXS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CDXS Due diligence Resources & Stock Charts

The CDXS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CDXS Detailed Price Forecast - CNN Money CNN View CDXS Detailed Summary - Google Finance
Yahoo View CDXS Detailed Summary - Yahoo! Finance Zacks View CDXS Stock Research & Analysis -

Stock Analysis

TradeIdeas View CDXS Trends & Analysis - Trade-Ideas Barrons View CDXS Major Holders - Barrons
NASDAQ View CDXS Call Transcripts - NASDAQ Seeking View CDXS Breaking News & Analysis - Seeking Alpha
Spotlight View CDXS Annual Report - OTC Report View CDXS OTC Short Report -
TradeKing View CDXS Fundamentals - TradeKing Charts View CDXS SEC Filings - Bar Chart
WSJ View Historical Prices for CDXS - The WSJ Morningstar View Performance/Total Return for CDXS - Morningstar
MarketWatch View the Analyst Estimates for CDXS - MarketWatch CNBC View the Earnings History for CDXS - CNBC
StockMarketWatch View the CDXS Earnings - StockMarketWatch MacroAxis View CDXS Buy or Sell Recommendations - MacroAxis
Bullish View the CDXS Bullish Patterns - American Bulls Short Pains View CDXS Short Pain Metrics -

Social Media Mentions

StockTwits View CDXS Stock Mentions - StockTwits PennyStocks View CDXS Stock Mentions - PennyStockTweets
Twitter View CDXS Stock Mentions - Twitter Invest Hub View CDXS Investment Forum News - Investor Hub
Yahoo View CDXS Stock Mentions - Yahoo! Message Board Seeking Alpha View CDXS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CDXS - Insider Cow View Insider Transactions for CDXS - Insider Cow
CNBC View CDXS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CDXS - OTC Markets
Yahoo View Insider Transactions for CDXS - Yahoo! Finance NASDAQ View Institutional Holdings for CDXS - NASDAQ

Stock Charts

FinViz View CDXS Stock Insight & Charts - StockCharts View CDXS Investment Charts -
BarChart View CDXS Stock Overview & Charts - BarChart Trading View View CDXS User Generated Charts - Trading View

Latest Financial News for CDXS

Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development
Posted on Wednesday July 11, 2018

Codexis, Inc. (CDXS), a leading protein engineering company, announces the appointment of Hicham Alaoui, Ph.D. to the newly created position of Vice President, Biotherapeutics Research & Development. The appointment brings Dr. Alaoui’s unique drug discovery skills and talents to Codexis at a pivotal time as the company expands its Biotherapeutics business and works to follow recent success in bringing its first drug candidate, CDX-6114 for potential treatment of phenylketonuria (PKU), into early clinical trials.

Codexis Doses First Subjects in Phase 1a Trial of CDX-6114
Posted on Monday July 09, 2018

This randomized, double-blind, placebo-controlled Phase 1a trial is intended to evaluate the safety and tolerability of CDX-6114 in up to 32 healthy volunteers, with up to four cohorts receiving a single dose of CDX-6114 at increasingly higher dose levels. Codexis also expects to generate valuable pharmacology data from this study, which will support the future development of the drug candidate.

Free Technical Research on Clovis Oncology and Three More Biotech Equities
Posted on Friday July 06, 2018

LONDON, UK / ACCESSWIRE / July 6, 2018 / If you want a free Stock Review on CLVS sign up now at On Thursday, July 05, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. All sectors ended Thursday's trading session in bullish territories.

3 Growth Stocks I'd Buy Right Now
Posted on Thursday June 21, 2018

The world's top lithium producer, a biotech just hitting its stride, and America's top consumer lawn care specialist should be enticing for growth-seeking investors.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.